Literature DB >> 18631945

Elevated microsomal prostaglandin-E synthase-1 in Alzheimer's disease.

Uzma A Chaudhry1, Hean Zhuang, Barbara J Crain, Sylvain Doré.   

Abstract

BACKGROUND: The proinflammatory prostaglandin E(2) (PGE(2)) fluctuates over time in the cerebrospinal fluid of patients with Alzheimer's disease (AD), but the cerebral distribution and expression patterns of microsomal prostaglandin-E synthase (mPGES)-1 have not been compared with those of normal human brains.
METHODS: Middle frontal gyrus tissue from AD and age-matched control brains was analyzed by Western blot, immunofluorescence, and immunohistochemistry with mPGES-1-specific antibodies.
RESULTS: Western blotting revealed that mPGES-1 expression was significantly elevated in AD tissue. Furthermore, immunofluorescence of mPGES-1 was observed in neurons, microglia, and endothelial cells of control and AD tissue. Although mPGES-1 was consistently present in astrocytes of control tissue, it was present in only some astrocytes of AD tissue. Immunohistochemical staining suggested that mPGES-1 was elevated in pyramidal neurons of AD tissue when compared with controls.
CONCLUSIONS: The results suggest that mPGES-1 is normally expressed constitutively in human neurons, microglia, astrocytes, and endothelial cells but is up-regulated in AD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18631945      PMCID: PMC2500207          DOI: 10.1016/j.jalz.2007.10.015

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  48 in total

1.  The dual role of prostaglandin E(2) in excitotoxicity and preconditioning-induced neuroprotection.

Authors:  Tania F Gendron; Eric Brunette; Joseph S Tauskela; Paul Morley
Journal:  Eur J Pharmacol       Date:  2005-07-04       Impact factor: 4.432

2.  Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity.

Authors:  Takayuki Kawano; Josef Anrather; Ping Zhou; Laibaik Park; Gang Wang; Kelly A Frys; Alexander Kunz; Sunghee Cho; Marcello Orio; Costantino Iadecola
Journal:  Nat Med       Date:  2006-01-06       Impact factor: 53.440

3.  Amyloid beta peptide (25-35) activates protein kinase C leading to cyclooxygenase-2 induction and prostaglandin E2 release in primary midbrain astrocytes.

Authors:  Michael Hüll; Barbara Müksch; Ravi Shankar Akundi; Anne Waschbisch; Jeroen J M Hoozemans; Robert Veerhuis; Bernd L Fiebich
Journal:  Neurochem Int       Date:  2006-03-20       Impact factor: 3.921

4.  A beta vasoactivity: an inflammatory reaction.

Authors:  D Paris; T Town; T Parker; J Humphrey; M Mullan
Journal:  Ann N Y Acad Sci       Date:  2000-04       Impact factor: 5.691

Review 5.  Microglial EP2 as a new target to increase amyloid beta phagocytosis and decrease amyloid beta-induced damage to neurons.

Authors:  Feng-Shiun Shie; Kathleen S Montine; Richard M Breyer; Thomas J Montine
Journal:  Brain Pathol       Date:  2005-04       Impact factor: 6.508

6.  Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2.

Authors:  Makoto Murakami; Karin Nakashima; Daisuke Kamei; Seiko Masuda; Yukio Ishikawa; Toshiharu Ishii; Yoshihiro Ohmiya; Kikuko Watanabe; Ichiro Kudo
Journal:  J Biol Chem       Date:  2003-06-30       Impact factor: 5.157

7.  Prostaglandins of J series control heme oxygenase expression: potential significance in modulating neuroinflammation.

Authors:  Hean Zhuang; Yun-Sook Kim; Khodadad Namiranian; Sylvain Doré
Journal:  Ann N Y Acad Sci       Date:  2003-05       Impact factor: 5.691

8.  Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs.

Authors:  J C Breitner; K A Welsh; M J Helms; P C Gaskell; B A Gau; A D Roses; M A Pericak-Vance; A M Saunders
Journal:  Neurobiol Aging       Date:  1995 Jul-Aug       Impact factor: 4.673

9.  Beta-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: involvement of the p38MAPK pathway.

Authors:  Maria Grazia Giovannini; Carla Scali; Costanza Prosperi; Arianna Bellucci; Maria Giuliana Vannucchi; Susanna Rosi; Giancarlo Pepeu; Fiorella Casamenti
Journal:  Neurobiol Dis       Date:  2002-11       Impact factor: 5.996

10.  Interleukin-1 mediates Alzheimer and Lewy body pathologies.

Authors:  W Sue T Griffin; Ling Liu; Yuekui Li; Robert E Mrak; Steven W Barger
Journal:  J Neuroinflammation       Date:  2006-03-16       Impact factor: 8.322

View more
  18 in total

Review 1.  Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis.

Authors:  William L Smith; Yoshihiro Urade; Per-Johan Jakobsson
Journal:  Chem Rev       Date:  2011-09-27       Impact factor: 60.622

2.  Microsomal prostaglandin E synthase-2: cellular distribution and expression in Alzheimer's disease.

Authors:  Uzma Chaudhry; Hean Zhuang; Sylvain Doré
Journal:  Exp Neurol       Date:  2009-08-05       Impact factor: 5.330

3.  Induction of COX-2 enzyme and down-regulation of COX-1 expression by lipopolysaccharide (LPS) control prostaglandin E2 production in astrocytes.

Authors:  Miriam Font-Nieves; M Glòria Sans-Fons; Roser Gorina; Ester Bonfill-Teixidor; Angélica Salas-Pérdomo; Leonardo Márquez-Kisinousky; Tomàs Santalucia; Anna M Planas
Journal:  J Biol Chem       Date:  2012-01-04       Impact factor: 5.157

4.  Resveratrol inhibits prostaglandin formation in IL-1beta-stimulated SK-N-SH neuronal cells.

Authors:  Lena Wendeburg; Antonio Carlos Pinheiro de Oliveira; Harsharan S Bhatia; Eduardo Candelario-Jalil; Bernd L Fiebich
Journal:  J Neuroinflammation       Date:  2009-09-14       Impact factor: 8.322

Review 5.  Pathophysiological Roles of Cyclooxygenases and Prostaglandins in the Central Nervous System.

Authors:  Tatsurou Yagami; Hiromi Koma; Yasuhiro Yamamoto
Journal:  Mol Neurobiol       Date:  2015-09-02       Impact factor: 5.590

Review 6.  Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to Bedside.

Authors:  Avijit Dey; Xu Kang; Jiange Qiu; Yifeng Du; Jianxiong Jiang
Journal:  Trends Pharmacol Sci       Date:  2016-04-06       Impact factor: 14.819

Review 7.  Prostaglandin E2 synthases in neurologic homeostasis and disease.

Authors:  M Kerry O'Banion
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-04-22       Impact factor: 3.072

8.  International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1-4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions.

Authors:  Xavier Norel; Yukihiko Sugimoto; Gulsev Ozen; Heba Abdelazeem; Yasmine Amgoud; Amel Bouhadoun; Wesam Bassiouni; Marie Goepp; Salma Mani; Hasanga D Manikpurage; Amira Senbel; Dan Longrois; Akos Heinemann; Chengcan Yao; Lucie H Clapp
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

9.  Cytosolic prostaglandin E synthase: expression patterns in control and Alzheimer's disease brains.

Authors:  Uzma A Chaudhry; Sylvain Dore
Journal:  Am J Alzheimers Dis Other Demen       Date:  2008-11-10       Impact factor: 2.035

10.  Putative role of prostaglandin receptor in intracerebral hemorrhage.

Authors:  Shekher Mohan; Abdullah S Ahmad; Alexander V Glushakov; Chase Chambers; Sylvain Doré
Journal:  Front Neurol       Date:  2012-10-22       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.